Universal Corporation — Form 10-Q Summary
Business context and reporting period
The filing covers the three months ended June 30, 2023, Universal’s first quarter of fiscal 2024. The supplied metadata says “2022 Q1,” which does not match the filing’s stated reporting period. Universal supplies leaf tobacco and plant-based ingredients to business customers. Results are seasonal and the company cautions that one quarter may not indicate full-year performance.
Financial results
Amounts below are in millions of dollars, except per-share data and percentages. The comparable period is the three months ended June 30, 2022.
| Metric | June 2023 quarter | June 2022 quarter |
|---|---|---|
| Revenue | $517.7 | $429.8 |
| Gross margin | 16.7% | 18.5% |
| Operating income | $11.0 | $13.3 |
| Net income (loss) attributable to Universal | $(2.1) | $6.8 |
| Diluted earnings (loss) per share | $(0.08) | $0.27 |
| Cash used by operating activities | $(103.9) | $(225.8) |
| Capital expenditures | $18.0 | $15.1 |
Revenue grew 20%, primarily on higher tobacco sales prices and favorable tobacco product and geographic mix. Tobacco segment revenue was $443.9 million, up 28%, and operating income was $8.9 million, up 9%. Ingredients revenue fell 10% to $73.8 million; the segment recorded a $2.0 million operating loss versus $4.6 million of income a year earlier. Consolidated cost of goods sold rose 23%, faster than revenue, while selling, general and administrative expense increased 14% to $75.5 million. Interest expense increased $8.8 million to $15.5 million, mainly due to higher interest rates.
At June 30, 2023, cash and cash equivalents were $80.5 million. Notes payable and overdrafts were $359.8 million and long-term debt was $616.9 million; combined borrowings were about $976.8 million. Net debt as a share of net capitalization was approximately 42%, versus 41% a year earlier and 35% at March 31, 2023. The company reported $480 million available on its committed revolving credit facility and about $59 million in uncommitted credit lines, and said it was compliant with debt covenants. No long-term debt matures until fiscal 2028.
Material changes and management commentary
- Operating cash outflow improved by $121.9 million year over year, though remained substantial. Seasonal inventory purchases used cash; higher customer advances and deposits helped offset working-capital needs.
- Tobacco inventory was $1.1 billion, up $266.8 million from March 31. Uncommitted tobacco inventory was $175.2 million, or 16% of total tobacco inventory, compared with 15% at June 30, 2022.
- Management described tobacco demand as strong, forecast increased leaf tobacco production in fiscal 2024, and expected supply to remain undersupplied relative to demand. Shipments are expected to be weighted toward the second half of the fiscal year.
- Ingredients performance was below expectations amid soft customer demand and customers drawing down elevated inventories. Management said the inventory issue was expected to be temporary, while noting it had lasted longer than forecast. Expansion costs and write-downs following lower prices for some new-crop raw materials also weighed on results.
Outlook, risks, and unusual items
- Universal expects to spend approximately $65 million to $75 million on capital projects over the next 12 months, including investment in its ingredients platform. It gave no specific full-year earnings guidance in the supplied filing text.
- Business risks cited include seasonality and crop yields, weather, customer concentration, shipment timing, inflation and supply-chain costs, foreign exchange and interest rates, political and economic conditions, regulation, and demand for tobacco and plant-based ingredients.
- Brazil VAT assessments remain contested: the outstanding Santa Catarina assessment was approximately $10 million and the reduced Parana assessment approximately $3 million, including applicable interest as described. Management considered no loss probable for either matter and recorded no liability; resolution may take a long time.
- Other contingencies included approximately $1 million, primarily letters of credit. The company said other litigation and tax matters were not currently expected to materially affect its business or financial position, but an adverse resolution could materially affect a particular period.
- Universal reported no material changes to the risk factors in its fiscal 2023 Form 10-K. It used interest-rate and foreign-currency derivatives for risk management, not speculation. A hypothetical 1% change in short-term rates was estimated to change annual interest expense by approximately $6.7 million, partly mitigated by customer charges.
- The prior-year quarter included the sale of idled Tanzania operations, which affected income taxes and reduced interest expense by $1.8 million. No corresponding adjustment was reported for the current quarter.
Important facts for investors to verify
- Confirm the intended period: this is a quarter ended June 30, 2023, not a 2022 first-quarter filing.
- Track whether ingredients customer inventories normalize and whether the segment returns to profitability; review future inventory write-downs and platform investment costs.
- Monitor tobacco crop volumes, uncommitted inventory, shipment timing, customer advances, and seasonal borrowing needs.
- Assess the effect of interest rates and foreign exchange on interest expense, working capital, and hedging outcomes.
- Follow the Brazil VAT disputes, recoverability of VAT credits, and supplier-advance allowances, which were $26 million at June 30, 2023.
- Review execution and returns on the planned $65 million to $75 million of capital spending and the company’s dividend and debt capacity.